Beckley Execs Talk Phase 2b Data, Competition, and Phase 3 Plans

Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study

Beckley and atai Leadership Unpack Phase 2b Data, Take Aim at...

Beyond the Endpoint: Industry Voices Reflect on Compass’ Phase 3 Readout

It’s Time to Push Back: Meta’s War on Psychedelic Voices

Victoria Litman – The Future of Psychedelic Regulation Is Local

Pα+ Psychedelic Bulletin #202: Psychedelics Access ‘Within 12 Months’, RFK Jr....

Cautious Optimism, Lingering Questions: Researchers React to Compass’ Phase 3 Psilocybin...

Compass Pathways’ Psilocybin Clears First Phase 3 Hurdle

PS 25 Morning Show – Day Three

Load more